With an R&D investment of €4,401 million in 2010, our 15,000 associates work every day to discover innovative solutions that will preserve health and improve the quality of life of all 6.8 billion people living on our planet.

Through the projects carried out by our multidisciplinary teams, we are exploring new health horizons, both in our reference fields – such as Diabetes and Oncology – and in response to the specific needs of elderly patients, populations in the Asia-Pacific region and even those affected by rare diseases.

Our researchers and our partners, stirred by the same passion and subject to the same rigorous standards, collaborate in a spirit of openness and transparency, driven by a commitment to accelerate patient access to innovation.